Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety

The pharmaceutical giant argues waiving intellectual property protections could see scarce inputs snapped up making it harder to produce vaccines

• Full Story podcast: Is Australia stopping the world's poorest nations from accessing cheap vaccines?
• What is patent waiving and will it solve the global shortage?

Pfizer has warned Australia against joining a growing push to waive the intellectual property protections for Covid-19 vaccines, arguing it could actually harm vaccine supply and invite less safe copycats.

Pfizer Australia made the submission to a parliamentary inquiry into vaccine fraud, arguing that open-slather production could see scarce inputs snapped up making it harder to produce its vaccines, which form a large component of Australia's rollout.